Drug interactions with quinolone antibacterials.
The quinolone antibacterials are prone to many interactions with other drugs. Quinolone absorption is markedly reduced with antacids containing aluminium, magnesium and/or calcium and therapeutic failure may result. Other metallic ion-containing drugs, such as sucralfate, iron salts, and zinc salts, can also reduce absorption. Some of the newer quinolones inhibit the cytochrome P450 system, e.g. enoxacin, pefloxacin and ciprofloxacin. The toxicity of drugs that are metabolised by the cytochrome P450 system is enhanced by concomitant use of some quinolones. Ciprofloxacin, enoxacin and pefloxacin can increase theophylline concentrations to toxic values. The pharmacokinetics of warfarin and cyclosporin are unaffected. Ofloxacin, fleroxacin and temafloxacin have a low inhibitory effect on the cytochrome P450 system and a low interaction potential may result. The affinity of quinolones for the gamma-aminobutyric acid (GABA) receptor may induce CNS adverse effects; these effects are enhanced by some nonsteroidal anti-inflammatory drugs (NSAIDs).
Brouwers
J R
JR
Department of Pharmacy and Pharmacokinetics, Tjongerschans General Hospital, Heerenveen, The Netherlands.
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans
D042462:4-Quinolones; D000890:Anti-Infective Agents